Nicorandil inhibits oxidative stress-induced apoptosis in cardiac myocytes through activation of mitochondrial ATP-sensitive potassium channels and a nitrate-like effect

被引:58
|
作者
Nagata, K
Obata, K
Odashima, M
Yamada, A
Somura, F
Nishizawa, T
Ichihara, S
Izawa, H
Iwase, M
Hayakawa, A
Murohara, T
Yokota, M
机构
[1] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Clin Pathophysiol, Nagoya, Aichi 4668550, Japan
[3] Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi 4618673, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Equipment, Ctr Res & Educ, Nagoya, Aichi 4668550, Japan
关键词
nicorandil; cardiomyocytes; oxidative stress; apoptosis; mitochondria; ATP-sensitive potassium channels; nitric oxide;
D O I
10.1016/j.yjmcc.2003.09.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The anti-anginal drug nicorandil has been shown to inhibit apoptosis by activating mitochondrial ATP-sensitive potassium (K-ATP) channels. The possible contribution of the nitrate moiety of this drug to its anti-apoptotic effect has now been investigated in neonatal rat ventricular myocytes subjected to oxidative stress. Exposure of cultured myocytes to 100 mumol/l hydrogen peroxide (H2O2) increased the number of nuclei stained by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling technique as well as induced internucleosomal DNA fragmentation, loss of mitochondrial membrane potential, cytochrome c release into the cytosol, and activation of caspases-3 and -9, all of which are characteristics of apoptosis. Pretreatment of cells with nicorandil (100 mumol/l) inhibited these effects of H2O2. Both the mitochondrial K-ATP channel antagonist 5-hydroxydecanoate (5-HD) and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), an inhibitor of soluble guanylyl cyclase, attenuated the anti-apoptotic effect of nicorandil in concentration-dependent manners. Coapplication of ODQ (10 mumol/l) and 5-HD (500 mumol/l) completely abolished nicorandil-induced cytoprotection. The effect of nicorandil was also reduced by an inhibitor of cGMP-dependent protein kinase (KT5823, 1 mumol/l). The nitric oxide donor (+/-)-S-nitroso-N-acetylpenicillamine (SNAP, 50 mumol/l) mimicked the protective effect of nicorandil in a manner sensitive to ODQ but not to 5-HD. A cell-permeable cGMP analog, 8-bromo-cGMP. also reduced H2O2-induced apoptosis. The inhibition of the H2O2-induced activation of caspase-3, but not that of caspase-9, by nicorandil in the presence of 5-HD or by SNAP was reversed by the addition of dithiothreitol to the enzyme assay. Nicorandil inhibits oxidative stress-induced apoptosis in cardiac myocytes through a nitric oxide/cGMP-dependent mechanism as well as by activating mitochondrial K-ATP channels. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1505 / 1512
页数:8
相关论文
共 50 条
  • [31] Nicorandil, a Mitochondrial ATP-Sensitive Potassium Channel Opener, Protects Cardiomyocytes against alpha-B-Crystallin R120G-Induced Apoptosis
    Sanbe, Atsushi
    Koizumi, Erika
    Tezuka, Yu
    Nishigori, Hideo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 155P - 155P
  • [32] Diazoxide supplemented Celsior solution improves hypothermic heart preservation effect in rat through activation of mitochondrial ATP-sensitive potassium channel
    Yan, Zhikun
    Hu, Zhibing
    Pan, Xiaohua
    Chen, Yingying
    Zhang, Xiaoming
    Shen, Yueliang
    PHARMACEUTICAL BIOLOGY, 2009, 47 (11) : 1060 - 1066
  • [33] Hydrogen sulfide attenuates induction and prevents progress of the 6-hydroxydopamine-induced Parkinsonism in rat through activation of ATP-sensitive potassium channels and suppression of ER stress
    Minaei, Azita
    Sarookhani, Mohammad Reza
    Haghdoost-Yazdi, Hashem
    Rajaei, Farzad
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 423
  • [34] 5-Methoxytryptophan attenuates oxidative stress-induced downregulation of PINK1 and mitigates mitochondrial damage and apoptosis in cardiac myocytes
    Lee, Chii-Ming
    Chien, Tung-Chun Russell
    Wang, Juo-Shan
    Chen, Yu-Wei
    Chen, Chin-Yu
    Kuo, Cheng-Chin
    Chiang, Liang-Ting
    Wu, Kenneth K.
    Hsu, Wan-Tseng
    FREE RADICAL BIOLOGY AND MEDICINE, 2025, 232 : 398 - 411
  • [35] Pharmacological and molecular docking studies reveal that glibenclamide competitively inhibits diazoxide-induced mitochondrial ATP-sensitive potassium channel activation and pharmacological preconditioning
    Palacio, Plinio Bezerra
    Brito Lucas, Aline Maria
    de Lacerda Alexandre, Joana Varlla
    Oliveira Cunha, Pedro Lourenzo
    Ponte Viana, Yuana Ivia
    Albuquerque, Amanda Cabral
    Nunes Varela, Anna Lidia
    Facundo, Heberty Tarso
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 908
  • [36] ADRIAMYCIN INDUCED CARDIAC DYSFUNCTION IS ATTENUATED BY SELENIUM VIA RESTORING OXIDATIVE STRESS MEDIATED EXPRESSION OF ATP SENSITIVE POTASSIUM CHANNELS IN RATS
    Liu Zhongwei
    Zhu Haitao
    Chen Kunlun
    Niu Xiaolin
    Yang Guang
    Meng Zhe
    Qiu Chuan
    Gao Dengfeng
    HEART, 2013, 99 : A25 - A25
  • [37] Modulation of the mitochondrial ATP-sensitive potassium channel by cromakalim provides protection against CA1 neuronal injury induced by hypoxia and oxidative stress
    Wallis, RA
    Panizzon, KL
    JOURNAL OF NEUROTRAUMA, 2005, 22 (10) : 1168 - 1168
  • [38] ACTIVATION OF ATP-SENSITIVE K+ CHANNEL IN CARDIAC MYOCYTES UNDER OXIDATIVE STRESS - ROLE OF THE DNA-REPAIR ENZYME POLY(ADP-RIBOSE) POLYMERASE
    ALMRUD, JJ
    BHATNAGAR, A
    BIOPHYSICAL JOURNAL, 1994, 66 (02) : A329 - A329
  • [39] c-jun N-terminal kinase activates mitochondrial death machinery in oxidative stress-induced apoptosis of adult cardiac myocytes in vitro
    Aoki, H
    Kang, PM
    Matsuzaki, M
    Izumo, S
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 455A - 455A
  • [40] Glucagon-Like Peptide-1 Analog Liraglutide Attenuates Pressure-Overload Induced Cardiac Hypertrophy and Apoptosis through Activating ATP Sensitive Potassium Channels
    Xiao-Jie Bai
    Jun-Tao Hao
    Rong-Hua Zheng
    Cai-Ping Yan
    Jin Wang
    Cai-Hong Yang
    Wei-Fang Zhang
    Zhi-Qing Zhao
    Cardiovascular Drugs and Therapy, 2021, 35 : 87 - 101